Literature DB >> 7020988

Lipid and lipoprotein abnormalities in alcoholic liver disease.

S M Sabesin.   

Abstract

Excessive alcohol ingestion results in profound derangements of lipid and lipoprotein metabolism, reflecting the effects of ethanol on peripheral and hepatic lipid metabolism and its toxic effects on hepatic function. The alterations in plasma lipids and lipoproteins are secondary to complex abnormalities of lipoprotein synthesis, secretion and catabolism. The major effects of alcohol include fatty liver secondary to excessive triglyceride synthesis, resulting in an imbalance between synthesis and hepatic secretion; hypertriglyceridemia and hypercholesterolemia; defective plasma cholesterol esterification; and decreased high-density lipoprotein cholesterol. In patients with severe alcoholic hepatitis, the plasma lipoproteins have an abnormal structure and apoprotein composition. Although these changes are usually reversible with abstinence from alcohol (if liver function returns to normal), they indicate serious effects of alcohol on the liver, which may culminate in cirrhosis and hepatic insufficiency. These effects of alcohol on lipids and lipoproteins should be contrasted with the elevation in high-density lipoprotein cholesterol concentration produced by moderate alcohol intake and the possibility that this increase may protect against the development of atherosclerotic disease.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7020988

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

Review 1.  Laboratory models available to study alcohol-induced organ damage and immune variations: choosing the appropriate model.

Authors:  Nympha B D'Souza El-Guindy; Elizabeth J Kovacs; Philippe De Witte; Claudia Spies; John M Littleton; Willem J S de Villiers; Amanda J Lott; Timothy P Plackett; Nadine Lanzke; Gary G Meadows
Journal:  Alcohol Clin Exp Res       Date:  2010-06-25       Impact factor: 3.455

2.  A salmon protein hydrolysate exerts lipid-independent anti-atherosclerotic activity in ApoE-deficient mice.

Authors:  Cinzia Parolini; Rita Vik; Marco Busnelli; Bodil Bjørndal; Sverre Holm; Trond Brattelid; Stefano Manzini; Giulia S Ganzetti; Federica Dellera; Bente Halvorsen; Pål Aukrust; Cesare R Sirtori; Jan E Nordrehaug; Jon Skorve; Rolf K Berge; Giulia Chiesa
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

3.  The effect of the severity of liver cirrhosis on the level of lipids and lipoproteins.

Authors:  Lech Chrostek; Lukasz Supronowicz; Anatol Panasiuk; Bogdan Cylwik; Ewa Gruszewska; Robert Flisiak
Journal:  Clin Exp Med       Date:  2014-11       Impact factor: 3.984

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.